What does CUSIP G4444C102 represent in this 13F holders report?

CUSIP G4444C102 is the security identifier for HLXA - MOONLAKE IMMUNOTHERAPEUTICS - COM used to aggregate holder disclosures.

How many institutions held HLXA - MOONLAKE IMMUNOTHERAPEUTICS - COM in Q4 2024?

1 institutional investor reported HLXA - MOONLAKE IMMUNOTHERAPEUTICS - COM for Q4 2024. Use the holders table for investor-level position and value details.

MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA)

CUSIP: G4444C102

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class: Equity / COM
Total 13F shares: 171,600
Share change: +5,000
Total reported value: $9,292,140
Price per share: $54.15
Number of holders: 1
Value change: +$270,750
Number of buys: 1

Quarterly Holders Quick Answers

What is CUSIP G4444C102?
CUSIP G4444C102 identifies HLXA - MOONLAKE IMMUNOTHERAPEUTICS - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2025
Previous quarter: Q3 2024

Recent filing periods for CUSIP G4444C102:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Institutional Holders of MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA) as of Q4 2024

As of 31 Dec 2024, MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 171,600 shares. The largest 1 holders included Decheng Capital LLC. This page lists 1 institutional shareholders reporting positions in this security for the Q4 2024 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.